Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001 - Wikidata - wikimedia - TriplyDB

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

http://www.wikidata.org/entity/Q28469286

about

Tuberculosis: current situation, challenges and overview of its control programs in India Isoniazid Prophylactic Therapy for the Prevention of Tuberculosis in HIV Infected Adults: A Systematic Review and Meta-Analysis of Randomized Trials Incidence of HIV-associated tuberculosis among individuals taking combination antiretroviral therapy: a systematic review and meta-analysis Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.AIDS-related tuberculosis in Rio de Janeiro, Brazil.The HIV-Brazil cohort study: design, methods and participant characteristics.Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.In-hospital mortality of disseminated tuberculosis in patients infected with the human immunodeficiency virus.Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis Outcomes of TB treatment by HIV status in national recording systems in Brazil, 2003-2008.Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.Antiretroviral therapy for tuberculosis control in nine African countries.Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.Systematic review of TST responses in people living with HIV in under-resourced settings: implications for isoniazid preventive therapy.Epidemiology of HIV-associated tuberculosis.Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings.Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection The proportions of people living with HIV in low and middle-income countries who test tuberculin skin test positive using either a 5 mm or a 10 mm cut-off: a systematic review.Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence.Antiretroviral treatment as prevention: impact of the 'test and treat' strategy on the tuberculosis epidemic.Pathogenesis of HIV and the lung Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.High rates of tuberculosis in patients accessing HAART in rural South Africa.Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database.Management of tuberculosis and latent tuberculosis infection in human immunodeficiency virus-infected persons.Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.Implementing an isoniazid preventive therapy program for people living with HIV in Thailand.Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.

P2860

Q24603827-E36789C3-1CB9-4B8F-ACF3-9B1F3D0AF41C Q26778385-09997E87-EC90-4A85-8CDE-822E7D4E7B11 Q27012753-CD689597-ED4F-40BF-8886-1DC61F745CC5 Q28743478-0F56B576-568B-4E89-850C-6DD74D114F78 Q30240445-649DFBF9-0C7D-49AB-A47A-3B0452DEC718 Q33368050-DC16FA43-47CF-4AFB-BEFC-20C215161124 Q33553184-B5785B69-1BFD-4B82-97BC-371BAFB74A53 Q33580153-4FBFAB08-E29E-4E7C-81D7-3CC5531EC4D5 Q33920318-8F9FD766-BF70-489A-B537-F1AB5BC03764 Q34089192-6D2071A3-D0A6-4DD0-8C48-DA29FAC9678A Q34146085-BD66CE62-1576-44B7-8E0B-0F4026CF7C5E Q34211754-6E51A49C-3520-4A03-9CB9-2A3E2C1B843A Q34213437-D1D2918A-1E6A-49CA-87E3-D98A71DBDC95 Q34320245-5606563E-CA50-4B2D-8EC1-B21F87DC4F00 Q34387168-33D7E5F4-A149-4A1D-8FD1-DED65CFB776C Q34499835-585F17CB-FED8-49BB-930A-B4AD6C83ADA6 Q34519940-08AFFC92-3003-4BAC-A3C0-A46193CCF7E4 Q34532773-6660981E-4EA1-40BC-80B5-44B66CC5881F Q34649281-A266A3CE-CC78-4C6A-A4F0-BD0AC3082CDB Q34802722-BEFF90AE-7E94-4754-B18A-36C5D96EFE4C Q34914625-02F62500-6392-4625-ACE7-2EE169F3B68E Q35514622-FD8C8D10-21E2-4890-8B1E-13A37FAF4A0A Q35870509-41740F13-0722-4101-9FFE-205E1A288DF9 Q36082304-D4D29C9C-2FD6-40C7-BFFD-D9DCCF815527 Q36479517-96CD27B0-493C-4E0B-B96B-AAF54758EA26 Q36509003-31A2B5D8-A424-4848-9147-606682769FD6 Q36594970-8C97FB0A-B215-472C-928F-0BEEFFE1567E Q36950190-24C722CE-CCE7-42DB-B9A7-7EE63A0AAF89 Q37461125-59D1C966-C9F2-493E-AE2B-972EA43C7616 Q37465373-7800D31F-A573-4393-9E63-79C21D6A6CCA Q37619616-4163AD02-C440-4A65-A6C0-B2995E12F290 Q37626250-A3951C1C-9D0A-4534-9AB3-950B47D094BD Q38107500-E749CE93-AA43-4986-9ACB-29CD520DA5E4 Q38855709-9F6B157D-B697-4E06-9088-A6F355343BC0 Q42364307-105ADF92-5D2F-4838-BA72-2CDF24E967FB Q45233459-77E20CC6-C53F-4AAF-B7CE-7F91C1B940BD Q47641918-DBECEAFD-9A3F-4B9F-8B7B-D3C098E403BC

P2860

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

http://www.wikidata.org/entity/Q28469286

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@ast

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@en

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@nl

type

label

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@ast

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@en

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@nl

prefLabel

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@ast

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@en

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@nl

P1433

Q28469286-8286114F-1185-40CC-832C-7A7E1AE7FAE0

P1476

Q28469286-383C879E-5CD3-4D7F-9467-23D6D91C65C7

P2093

Q28469286-018EA61F-C772-4D1F-8706-0E58002ADB32

Q28469286-1BA0EB87-4594-48CA-A83E-82FB5ED85B3F

Q28469286-7E1248BB-A18B-491D-9886-8F97B369A7B4

Q28469286-9F9FBB02-AD1D-4094-9DED-1255AC0DFBFE

Q28469286-A7242A17-98D4-49E3-98ED-B2DE7BCC367B

Q28469286-A77343B9-FE72-48A1-A779-3B9617374751

Q28469286-C2D2CE46-CED5-4A3E-89FA-B67B4CF9F8D3

Q28469286-E5FD93F8-3ECA-4ABC-A6E9-EA25C0ECD2D2

Q28469286-E9492585-F2CB-4450-8F71-40CBD5882BC3

Q28469286-F67586FE-DE05-465E-8D6F-BC0C2D85303B

P2860

Q28469286-01296EE7-C235-427C-8102-8ECBA5AB4268

Q28469286-0C84AF0D-D886-4EE6-BAFB-838060FA1C26

Q28469286-12CC4577-28F2-4B42-AC5B-892D0C4B4739

Q28469286-17E6235E-41C8-4C37-9D5C-2827E6B8CFFE

Q28469286-2DF7197A-97B2-41FB-BF02-89DB49CC08C1

Q28469286-3128BDD0-96F8-4D84-BDAC-6D553457ADEA

Q28469286-37859CF5-DE1B-4DC7-B904-B9DDE76C107A

Q28469286-392F489E-CC76-40C4-B884-70B600F4CCBB

Q28469286-58DDBCE2-8216-44A6-A295-5CA7A63712F4

Q28469286-5D422493-4DB2-4F82-9205-51808C5D13D1

P304

Q28469286-CDB41599-5BFC-4143-8BE5-19F316A91AA8

P31

Q28469286-52B779CD-E75A-4DC2-80C6-D7AD57F6558F

P356

Q28469286-F03B61A6-2EB1-4DF4-AED3-BCA1CAEB0E28

P407

Q28469286-FC09992D-1B4F-47A5-9B85-870BCF81CAC6

P433

Q28469286-C414CC58-1231-431B-B152-6A2B433AC083

P478

Q28469286-FAB3E25F-04BD-40F7-ABB7-B9D167E0C057

P577

Q28469286-FF4D0188-1EA3-41C9-B096-8F990D0DD15B

P5875

Q28469286-3BC0EDA5-0C69-4154-8A7C-4ED7FF82BD6A

P698

Q28469286-4CCCDC0D-F950-46BA-AF56-ADD763D05952

P921

Q28469286-BB772C3E-742E-49E4-AB62-4B0A3093B3D6

Q28469286-F163E4C9-55D5-4AE9-AEBB-CA753D41B757

P932

Q28469286-CCC5690C-EC79-4143-9CF1-AFDE8E072DE1

P356

JOURNAL.PONE.0000826

P1433

P1476

Impact of antiretroviral thera ...... razilian experience, 1995-2001

@en

P2093

Abraham Miranda

http://www.w3.org/2001/XMLSchema#string

Charles Wells

http://www.w3.org/2001/XMLSchema#string

Denise Garrett

http://www.w3.org/2001/XMLSchema#string

Draurio Barreira

http://www.w3.org/2001/XMLSchema#string

Guida Silva

http://www.w3.org/2001/XMLSchema#string

Joseney Santos

http://www.w3.org/2001/XMLSchema#string

Kayla Laserson

http://www.w3.org/2001/XMLSchema#string

Leda Jamal

http://www.w3.org/2001/XMLSchema#string

Meade Morgan

http://www.w3.org/2001/XMLSchema#string

Patricia Paine

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy.

Interim proposal for a WHO Staging System for HIV infection and Disease

Fighting against AIDS

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

Dynamics and control of the global tuberculosis epidemic.

Nosocomial epidemic of active tuberculosis among HIV-infected patients.

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.

Can we control tuberculosis in high HIV prevalence settings?

P304

e826

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0000826

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6054729

http://www.w3.org/2001/XMLSchema#string

P698

17786198

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

antiretroviral drug

P932

1952142

http://www.w3.org/2001/XMLSchema#string